Assessment of response to neoadjuvant chemotherapy in advanced ovarian cancer: does the level of CA125 predict an optimal debulking surgery?

被引：0
|
作者：
Ben Ltaief, Sarra [1 ]
Bouhani, Malek [1 ]
Mbarek, Mohamed Mahdi Ben [1 ]
Sakhri, Saida [1 ]
Bouaziz, Hanen [1 ]
Ben Dhiab, Tarek [1 ]
机构：
[1] Inst Salah Aziez Tunisia, Surg Oncol, Tunis Ville, Tunisia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV226/#752
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [31] Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy
    Poddar, Pabashi
    Patel, Shilpa
    Arora, Ruchi
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 21 (03)
  • [32] Neoadjuvant chemotherapy with interval debulking surgery versus chemotherapy alone for advanced epithelial ovarian cancer
    Khouri, Olivia
    Fazzari, Melissa
    Katcher, Arielle
    Nevadunsky, Nicole
    Fife, Alexander
    Isani, Sara
    Smotkin, David
    Kuo, Dennis Yi-Shin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S209 - S210
  • [33] Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?
    Akladios, Cherif
    Baldauf, Jean-Jacques
    Marchal, Frederic
    Hummel, Michel
    Rebstock, Laure-Emilie
    Kurtz, Jean-Emmanuel
    Petit, Thierry
    Afors, Karolina
    Mathelin, Carole
    Lecointre, Lise
    Schrot-Sanyan, Stephanie
    ONCOLOGY, 2016, 91 (06) : 331 - 340
  • [34] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Ce Bian
    Kui Yao
    Li Li
    Tao Yi
    Xia Zhao
    Archives of Gynecology and Obstetrics, 2016, 293 : 163 - 168
  • [35] The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery
    Zeng, Jing
    Huang, Huizhen
    Shan, Ying
    Li, Yan
    Jin, Ying
    Pan, Lingya
    JOURNAL OF CANCER, 2017, 8 (17): : 3410 - 3415
  • [36] Neoadjuvant chemotherapy and interval debulking surgery for advanced ovarian cancer, an alternative with multiple advantages
    Medina-Franco, Heriberto
    Mejia-Fernandez, Loreli
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [37] Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy
    Jorgensen, Kirsten
    Melamed, Alexander
    Wu, Chi-Fang
    Nitecki, Roni
    Pareja, Rene
    Fagotti, Anna
    Schorge, John O.
    Ramirez, Pedro T.
    -Hain, Jose Alejandro Rauh
    GYNECOLOGIC ONCOLOGY, 2023, 172 : 130 - 137
  • [38] IS LAPAROSCOPIC INTERVAL DEBULKING SURGERY ACHIEVABLE FOR ADVANCED OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY?
    Pellerin, M.
    Lecointre, L.
    Billard-Martel, C.
    Boisrame, T.
    Faller, E.
    Fabacher, T.
    Akladios, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A271 - A271
  • [39] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Bian, Ce
    Yao, Kui
    Li, Li
    Yi, Tao
    Zhao, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (01) : 163 - 168
  • [40] Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer
    Cowan, Renee A.
    Chi, Dennis S.
    Fagotti, Anna
    Scambia, Giovanni
    ONCOLOGY-NEW YORK, 2017, 31 (06): : 453 - +
12345